| UC Berkeley BioExec Institute - Managing Value | |
|
United States - CA - Berkleey |
|
| Hosted by: | UC Berkeley Center for Executive Education |
| Venue: | UC Berkeley |
| Dates: | Nov 07, 2012 through Nov 08, 2012 |
| Event Registration: | 2012-01-01 through 2012-11-07 |
|
Description |
|
| Companies often start development on new or improved products because of great technological innovations in the lab. But, ultimately, it is the market - the customer - who decides whether your product is valuable or not. Planning for commercial success starts at the research stage and parallels the entire R&D process. During this session, industry leaders will explore product commercialization, second generation products and potential exit strategies, all in an effort to determine the best way to optimize the value of innovation over time. The content in this session will range from high-level strategic trade-offs to detailed calculations of value (both quantitative and qualitative) and from debating options to understanding the path for optimizing your company’s assets. Featured Topics: • Critical commercial decision points during the research and development phase of drugs • Research and development decisions that have substantial commercial impact in the future • Benefits and risks associated with commercial decisions during the development process • Appropriate assessment of the commercial value of your asset • Recognizing key commercial value drivers • Value appropriate and relevant commercial input in the value chain • Gain an appreciation for the pre-launch/launch and post-launch marketing activities • Recognizing the critical commercial input to optimize your asset |
|
| Additional Information | |
| Event URL: | http://executive.berkeley.edu/programs/bioexec-institute |
| ISCB Member Discount: | None |
| Contact Person: | Chelsea Hewitt ([javascript protected email address]) |
While ISCB provides for conference and event listings that may be of interest to members and bioinformaticians at large, ISCB is not responsible for the content provided by outside sources. Such listings are not meant as an endorsement by ISCB.
